首页> 外文期刊>Helicobacter >Protection against Helicobacter pylori infection in Mongolian gerbil by intragastric or intramuscular administration of H-Pylori multicomponent vaccine
【24h】

Protection against Helicobacter pylori infection in Mongolian gerbil by intragastric or intramuscular administration of H-Pylori multicomponent vaccine

机译:通过胃内或肌肉内注射H-幽门螺杆菌多组分疫苗预防蒙古沙鼠的幽门螺杆菌感染

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Development of Helicobacter pylori vaccine would be a new effective strategy for prevention and treatment of H. pylori infection. Recombinant H. pylori vaccine comprising a single subunit antigen can only induce immune response with limited protection efficiency. In this study, the protective effect of H. pylori multicomponent vaccines consisting of three recombinant subunit antigens was investigated using the Mongolian gerbil model. Materials and methods: Mongolian gerbils were immunized with different formulations of three recombinant H. pylori antigens (UreB, HspA, and HpaA) with two different adjuvants (Al(OH)(3), LTR72DITH) by intragastric (i.g.) or intramuscular (i.m.) routes. The protective effects of multicomponent vaccines were assessed after H. pylori challenge in different studies. The specific IgG antibodies in serum were monitored by ELISA, and the mRNA expressions of IL-4 and IFN-gamma in spleen tissue were detected by reverse transcribed polymerase chain reaction (RT-PCR). Results: The protective effect against H. pylori challenge in gerbils immunized with three recombinant antigens and LTR72DITH or Al(OH)(3) was significantly higher than that in single- or double-antigen vaccine-immunized and control gerbils. Furthermore, the protective effect of the triple-antigen vaccine combined with the LTR72DITH adjuvant (average 86.3%) was significantly greater than that of vaccine combined with the Al(OH)(3) adjuvant (average 53.4%). After the first immunization, the anti-UreB/HspA/HpaA serum IgG level in gerbils immunized with triple-antigen vaccine combined with Al(OH)(3) was higher than that in gerbils immunized with the vaccine combined with LTR72DITH. Splenic interferon (IFN)-gamma and interleukin (IL)-4 transcript levels were significantly increased in LTR72DITH vaccine-immunized gerbils as compared to the Al(OH)(3) vaccine group. Moreover, splenic IL-4 mRNA levels were higher than IFN-gamma in gerbils immunized with triple-antigen vaccine with either LTR72DITH or Al(OH)(3). Conclusions: This study indicated that the recombinant multicomponent vaccine provided effective protection against H. pylori infection as compared to the single-antigen vaccine. This protective immunity would be closely associated with a predominant Th2-type response.
机译:背景:开发幽门螺杆菌疫苗将是预防和治疗幽门螺杆菌感染的一种新的有效策略。包含单个亚基抗原的重组幽门螺杆菌疫苗只能诱导免疫反应,保护效率有限。在这项研究中,使用蒙古沙鼠模型研究了由三种重组亚基抗原组成的幽门螺杆菌多组分疫苗的保护作用。材料和方法:通过三种不同的佐剂(Al(OH)(3),LTR72DITH),通过胃内(ig)或肌内(im)的三种重组幽门螺杆菌抗原(UreB,HspA和HpaA)的不同制剂免疫蒙古沙鼠。 )路线。在不同的研究中,在幽门螺杆菌攻击后评估了多组分疫苗的保护作用。通过ELISA监测血清中的特异性IgG抗体,并通过逆转录聚合酶链反应(RT-PCR)检测脾脏中IL-4和IFN-γ的mRNA表达。结果:用三种重组抗原和LTR72DITH或Al(OH)(3)免疫的沙鼠对幽门螺杆菌攻击的保护作用显着高于单抗原或双抗原疫苗免疫和对照的沙鼠。此外,三抗原疫苗结合LTR72DITH佐剂的保护作用(平均86.3%)显着大于结合Al(OH)(3)佐剂的疫苗的保护作用(平均53.4%)。首次免疫后,三抗原联合Al(OH)(3)疫苗免疫的沙鼠的抗UreB / HspA / HpaA血清IgG水平高于联合LTR72DITH疫苗免疫的沙鼠。与Al(OH)(3)疫苗组相比,LTR72DITH疫苗免疫的沙鼠的脾脏干扰素(IFN)-γ和白介素(IL)-4转录水平显着增加。此外,用LTR72DITH或Al(OH)(3)接种三抗原疫苗免疫的沙鼠脾脏IL-4 mRNA水平高于IFN-γ。结论:这项研究表明,与单抗原疫苗相比,重组多组分疫苗可有效抵抗幽门螺杆菌感染。这种保护性免疫力与主要的Th2型反应密切相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号